BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, August 3, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Jan. 26, 2022

Jan. 26, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, Achieve, Arcturus, Athira, Biomea, Biontech, Cartesian, Cerevance, Checkpoint, Chiesi, Cindome, Daewoong, Deciphera, ITM, Mina, Pfizer, Remegen, Sierra.
Read More

In the clinic for Jan. 18-24, 2022

Jan. 25, 2022
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Angel, Anges, Aslan, Calcimedica, Clover, Corvus, Cstone, Eisai, Elpiscience, Eqrx, HDT, Hinova, Hutchmed, I-Mab, Immvira, Keymed, Lynk, Merck, Recce, Resverlogix, Revelation, Revive, Sciwind, Sorrento, Vasomune.
Read More

In the clinic for Jan. 25, 2022

Jan. 25, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Intersect ENT.
Read More

In the clinic for Jan. 25, 2022

Jan. 25, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim, Arcturus, Ascletis, Basilea, Beigene, Biolinerx, Biothera, Connect, Erytech, Gensight, Harbour, Horizon, Innovent, Kalvista, Kintor, Lyra, Maat, Mediwound, Mirati, Mybiotics, Obi, Orchard, Panbela, SAB, Todos, Verona.
Read More

In the clinic for Jan. 24, 2022

Jan. 24, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Natera, Veracyte.
Read More

In the clinic for Jan. 24, 2022

Jan. 24, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aslan, Clover, Opiant, Provention, UCB.
Read More

In the clinic for Jan. 21, 2022

Jan. 21, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Braintale.
Read More

In the clinic for Jan. 21, 2022

Jan. 21, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arecor, Biovie, Calcimedica, Elpiscience, Hinova, Hutchmed, Idorsia, Infant Bacterial, Intelgenx, Merck, Oncolytic, Revelation, Seres, Sorrento, Vigeo, Xilio, Zealand.
Read More

In the clinic for Jan. 20, 2022

Jan. 20, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neovasc.
Read More

In the clinic for Jan. 20, 2022

Jan. 20, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cstone, Eisai, Eqrx, Essa, Immix, Immvira, Lynk, Recce, Revive, Sanofi, Vyne.


Read More
Previous 1 2 … 208 209 210 211 212 213 214 215 216 … 330 331 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 31, 2026.
  • Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

    BioWorld Science
    Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
  • Silhouette illustration of DNA gene editing

    Death in Chinese gene-editing trial exposes ethical fault lines

    BioWorld
    The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
  • Anthony Fauci at Senate hearing 7-29

    Fauci’s silence may put him in contempt of Congress

    BioWorld
    After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
  • Mitochondria

    Seed funding at Adjuvia to treat mitochondrial dysfunction

    BioWorld Science
    Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing